Absence of RIP140 reveals a pathway regulating glut4-dependent glucose uptake in oxidative skeletal muscle through UCP1-mediated activation of AMPK

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Fritah, Asmaà ^a,d   Steel, Jennifer H ^a   Parker, Nadeene ^b   Nikolopoulou, Evanthia ^a   Christian, Mark ^a   Carling, David ^c   Parker, Malcolm G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; PROTEIN KINASE B; RECEPTOR INTERACTING PROTEIN 140; UNCOUPLING PROTEIN 1; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTENSOR DIGITORUM LONGUS MUSCLE; FATTY ACID METABOLISM; GENE EXPRESSION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION UNCOUPLING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SOLEUS MUSCLE; ANIMAL; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; WESTERN BLOTTING;

MUS; MUS MUSCULUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOTTING, WESTERN; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; IMMUNOHISTOCHEMISTRY; ION CHANNELS; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION;

EID: 84857599194     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032520     Document Type: Article

References (61)

1. Bassel-Duby R, Olson EN, (2006) Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 75: 19-37.
2. Larsson L, Edstrom L, Lindegren B, Gorza L, Schiaffino S, (1991) MHC composition and enzyme-histochemical and physiological properties of a novel fast-twitch motor unit type. Am J Physiol 261: C93-101.
3. Schiaffino S, Reggiani C, (1996) Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 76: 371-423.
4. Baldwin KM, Haddad F, (2001) Effects of different activity and inactivity paradigms on myosin heavy chain gene expression in striated muscle. J Appl Physiol 90: 345-357.
5. Wu H, Gallardo T, Olson EN, Williams RS, Shohet RV, (2003) Transcriptional analysis of mouse skeletal myofiber diversity and adaptation to endurance exercise. J Muscle Res Cell Motil 24: 587-592.
6. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, et al. (2004) Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2: e294.
7. Izumiya Y, Hopkins T, Morris C, Sato K, Zeng L, et al. (2008) Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab 7: 159-172.
8. Carling D, Sanders MJ, Woods A, (2008) The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes (Lond) 32 (Suppl 4): S55-59.
9. Kahn BB, Alquier T, Carling D, Hardie DG, (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25.
10. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, et al. (2003) Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2: 28.
11. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, et al. (2005) Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2: 9-19.
12. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, et al. (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271: 27879-27887.
13. Sanders MJ, Grondin PO, Hegarty BD, Snowden MA, Carling D, (2007) Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J 403: 139-148.
14. Winder WW, Hardie DG, (1996) Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 270: E299-304.
15. Dzamko N, Schertzer JD, Ryall JG, Steel R, Macaulay SL, et al. (2008) AMPK-independent pathways regulate skeletal muscle fatty acid oxidation. J Physiol 586: 5819-5831.
16. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ, (1998) Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369-1373.
17. Russell RR 3rd, Bergeron R, Shulman GI, Young LH, (1999) Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 277: H643-649.
18. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, et al. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345: 790-797.
19. Fryer LG, Parbu-Patel A, Carling D, (2002) The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277: 25226-25232.
20. Zhou G, Myers R, Li Y, Chen Y, Shen X, et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174.
21. Christian M, Kiskinis E, Debevec D, Leonardsson G, White R, et al. (2005) RIP140-targeted repression of gene expression in adipocytes. Mol Cell Biol 25: 9383-9391.
22. Herzog B, Hallberg M, Seth A, Woods A, White R, et al. (2007) The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor. Mol Endocrinol 21: 2687-2697.
23. Leonardsson G, Steel JH, Christian M, Pocock V, Milligan S, et al. (2004) Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci U S A 101: 8437-8442.
24. Powelka AM, Seth A, Virbasius JV, Kiskinis E, Nicoloro SM, et al. (2006) Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J Clin Invest 116: 125-136.
25. Seth A, Steel JH, Nichol D, Pocock V, Kumaran MK, et al. (2007) The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle. Cell Metab 6: 236-245.
26. Treuter E, Albrektsen T, Johansson L, Leers J, Gustafsson JA, (1998) A regulatory role for RIP140 in nuclear receptor activation. Mol Endocrinol 12: 864-881.
27. L'Horset F, Dauvois S, Heery DM, Cavailles V, Parker MG, (1996) RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol Cell Biol 16: 6029-6036.
28. Castet A, Herledan A, Bonnet S, Jalaguier S, Vanacker JM, et al. (2006) Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes. Mol Endocrinol 20: 1035-1047.
29. Francis GA, Fayard E, Picard F, Auwerx J, (2003) Nuclear receptors and the control of metabolism. Annu Rev Physiol 65: 261-311.
30. Huss JM, Torra IP, Staels B, Giguere V, Kelly DP, (2004) Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol Cell Biol 24: 9079-9091.
31. Kamei Y, Ohizumi H, Fujitani Y, Nemoto T, Tanaka T, et al. (2003) PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc Natl Acad Sci U S A 100: 12378-12383.
32. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, et al. (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797-801.
33. Fritah A, Christian M, Parker MG, (2010) The metabolic coregulator RIP140: An update. Am J Physiol Endocrinol Metab 299 (3): E335-340.
34. Fritah A, (2009) Control of skeletal muscle metabolic properties by the nuclear receptor corepressor RIP140. Appl Physiol Nutr Metab 34: 362-367.
35. Fritah A, Steel JH, Nichol D, Parker N, Williams S, et al. (2010) Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function. Cardiovasc Res 86 (3): 443-451.
36. Kiskinis E, Hallberg M, Christian M, Olofsson M, Dilworth SM, et al. (2007) RIP140 directs histone and DNA methylation to silence Ucp1 expression in white adipocytes. Embo J 26: 4831-4840.
37. Klaus S, Casteilla L, Bouillaud F, Ricquier D, (1991) The uncoupling protein UCP: a membraneous mitochondrial ion carrier exclusively expressed in brown adipose tissue. Int J Biochem 23: 791-801.
38. White R, Leonardsson G, Rosewell I, Ann Jacobs M, Milligan S, et al. (2000) The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility. Nat Med 6: 1368-1374.
39. Tsai NP, Lin YL, Wei LN, (2009) MicroRNA mir-346 targets the 5′-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression. Biochem J 424: 411-418.
40. Rytinki MM, Palvimo JJ, (2008) SUMOylation modulates the transcription repressor function of RIP140. J Biol Chem 283: 11586-11595.
41. Potthoff MJ, Wu H, Arnold MA, Shelton JM, Backs J, et al. (2007) Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest 117: 2459-2467.
42. Hallberg M, Morganstein DL, Kiskinis E, Shah K, Kralli A, et al. (2008) A functional interaction between RIP140 and PGC-1alpha regulates the expression of the lipid droplet protein CIDEA. Mol Cell Biol 28: 6785-6795.
43. Jager S, Handschin C, St-Pierre J, Spiegelman BM, (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A 104: 12017-12022.
44. Arany Z, Lebrasseur N, Morris C, Smith E, Yang W, et al. (2007) The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab 5: 35-46.
45. Cannon B, Nedergaard J, (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84: 277-359.
46. Carroll AM, Haines LR, Pearson TW, Brennan C, Breen EP, et al. (2004) Immunodetection of UCP1 in rat thymocytes. Biochem Soc Trans 32: 1066-1067.
47. Kalaany NY, Gauthier KC, Zavacki AM, Mammen PP, Kitazume T, et al. (2005) LXRs regulate the balance between fat storage and oxidation. Cell Metab 1: 231-244.
48. Chen W, Zhang X, Birsoy K, Roeder RG, (2010) A muscle-specific knockout implicates nuclear receptor coactivator MED1 in the regulation of glucose and energy metabolism. Proc Natl Acad Sci U S A 107: 10196-10201.
49. Seale P, Bjork B, Yang W, Kajimura S, Chin S, et al. (2008) PRDM16 controls a brown fat/skeletal muscle switch. Nature 454: 961-967.
50. Timmons JA, Wennmalm K, Larsson O, Walden TB, Lassmann T, et al. (2007) Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci U S A 104: 4401-4406.
51. Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, et al. (2000) Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6: 924-928.
52. Li B, Nolte LA, Ju JS, Han DH, Coleman T, et al. (2000) Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice. Nat Med 6: 1115-1120.
53. Neschen S, Katterle Y, Richter J, Augustin R, Scherneck S, et al. (2008) Uncoupling protein 1 expression in murine skeletal muscle increases AMPK activation, glucose turnover, and insulin sensitivity in vivo. Physiol Genomics 33: 333-340.
54. Foretz M, Hebrard S, Leclerc J, Zarrinpashneh E, Soty M, et al. (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest 120: 2355-2369.
55. Ho PC, Lin YW, Tsui YC, Gupta P, Wei LN, (2009) A negative regulatory pathway of GLUT4 trafficking in adipocyte: new function of RIP140 in the cytoplasm via AS160. Cell Metab 10: 516-523.
56. Mostaqul Huq MD, Gupta P, Tsai NP, White R, Parker MG, et al. (2006) Suppression of receptor interacting protein 140 repressive activity by protein arginine methylation. Embo J 25: 5094-5104.
57. Nielsen JN, Mustard KJ, Graham DA, Yu H, MacDonald CS, et al. (2003) 5′-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631-641.
58. Salt I, Celler JW, Hawley SA, Prescott A, Woods A, et al. (1998) AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem J 334 (Pt 1): 177-187.
59. Wojtaszewski JF, Birk JB, Frosig C, Holten M, Pilegaard H, et al. (2005) 5′AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes. J Physiol 564: 563-573.
60. Nautiyal J, Steel JH, Rosell MM, Nikolopoulou E, Lee K, et al. (2010) The Nuclear Receptor Cofactor Receptor-Interacting Protein 140 Is a Positive Regulator of Amphiregulin Expression and Cumulus Cell-Oocyte Complex Expansion in the Mouse Ovary. Endocrinology 151 (6): 2923-2932.
61. Zschiedrich I, Hardeland U, Krones-Herzig A, Berriel Diaz M, Vegiopoulos A, et al. (2008) Coactivator function of RIP140 for NFkappaB/RelA-dependent cytokine gene expression. Blood 112: 264-276.